当前位置：
X-MOL 学术
›
Eur. J. Heart Fail.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A randomized clinical trial on the short-term effects of 12-week sacubitril/valsartan vs. enalapril on peak oxygen consumption in patients with heart failure with reduced ejection fraction: results from the ACTIVITY-HF study
European Journal of Heart Failure ( IF 18.2 ) Pub Date : 2021-09-30 , DOI: 10.1002/ejhf.2355 Martin Halle 1, 2 , Christoph Schöbel 3 , Ephraim B Winzer 4 , Peter Bernhardt 5 , Stephan Mueller 1, 2 , Christian Sieder 6 , Laura S M Lecker 6
European Journal of Heart Failure ( IF 18.2 ) Pub Date : 2021-09-30 , DOI: 10.1002/ejhf.2355 Martin Halle 1, 2 , Christoph Schöbel 3 , Ephraim B Winzer 4 , Peter Bernhardt 5 , Stephan Mueller 1, 2 , Christian Sieder 6 , Laura S M Lecker 6
Affiliation
|
ACTIVITY-HF was a randomized, double-blind, active-controlled study, which assessed the short-term effect of sacubitril/valsartan compared with the active comparator enalapril on improving maximal exercise capacity in patients with heart failure with reduced ejection fraction (HFrEF).
中文翻译：
一项关于 12 周沙库巴曲/缬沙坦与依那普利对射血分数降低的心力衰竭患者峰值耗氧量短期影响的随机临床试验：来自 ACTIVITY-HF 研究的结果
ACTIVITY-HF 是一项随机、双盲、主动对照研究，评估了沙库巴曲/缬沙坦与活性对比剂依那普利相比对改善射血分数降低心力衰竭 (HFrEF) 患者最大运动能力的短期效果.
更新日期：2021-09-30
中文翻译：
一项关于 12 周沙库巴曲/缬沙坦与依那普利对射血分数降低的心力衰竭患者峰值耗氧量短期影响的随机临床试验：来自 ACTIVITY-HF 研究的结果
ACTIVITY-HF 是一项随机、双盲、主动对照研究，评估了沙库巴曲/缬沙坦与活性对比剂依那普利相比对改善射血分数降低心力衰竭 (HFrEF) 患者最大运动能力的短期效果.
京公网安备 11010802027423号